Macquarie Group’s Vaxart VXRT Stock Holding History

Macquarie Group’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,985	Closed	-$6	–	2157
2024 Q1	$6	Buy	+4,985	New	+$5.22K	﹤0.01%	1775
2022 Q4	–	Sell	-7,511	Closed	-$20K	–	2138
2022 Q3	$20K	Sell	7,511 -1,679	-18%	-$5.79K	﹤0.01%	2204
2022 Q2	$32K	Hold	9,190	–	–	﹤0.01%	2177
2022 Q1	$46	Hold	9,190	–	–	﹤0.01%	2166
2021 Q4	$58K	Hold	9,190	–	–	﹤0.01%	2112
2021 Q3	$73K	Buy	9,190 +7,511	+447%	+$61.8K	﹤0.01%	2090
2021 Q2	$13K	Sell	1,679 -1,328	-44%	-$9.27K	﹤0.01%	2447
2021 Q1	$18K	Buy	+3,007	New	+$23.1K	﹤0.01%	2313

Other funds holding VXRT

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group's VXRT Position: Q2 2024 in Review

Macquarie Group sold out of Vaxart (VXRT) in Q2 2024, closing a stake of 4,985 shares — an estimated $6 sold.

Macquarie Group first reported a position in VXRT in Q1 2021 and held it in 8 quarters. The position peaked at $73K in Q3 2021. 100 funds tracked by Wall St. Rank hold VXRT as of Q2 2024.

Macquarie Group reported no remaining Vaxart position as of Q2 2024 after selling out during the quarter.
Macquarie Group sold 4,985 Vaxart shares in Q2 2024, an estimated $6.
Macquarie Group first reported a position in Vaxart in Q1 2021 and held it in 8 quarters.
Macquarie Group's Vaxart position peaked at $73K in Q3 2021.
100 funds tracked by Wall St. Rank held Vaxart as of Q2 2024.

Based on Macquarie Group's 13F filing for Q2 2024, filed 9 Aug 2024.